Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03825393Completed

Association of Ferritin Levels With Clinical Parameters in Patients With Fibromyalgia Syndrome

Role: lead

NCT05747950Not ApplicableCompleted

Different Treatment Methods Effect on Upper Extremity Spasticity and Decreased Functionality After Stroke

Role: collaborator

NCT03758183Completed

Cost Effectiveness of Prolotherapy Injections Prior to Total Knee Arthroplasty

Role: lead

All 3 trials loaded